The GLOW blend 70mg combines GHK-Cu, BPC-157 and TB-500 in a single vial — written variously as GLOW peptide, GLOW stack or GLOW 70mg — bringing together copper-binding, gut-related, and recovery-focused research peptides for researchers across Australia studying skin and tissue-related signalling. It is one of the more popular three-peptide combinations within Australian peptide research. PhaseOne has the GLOW blend for sale online as a high-purity lyophilised powder, independently HPLC verified at ≥99% purity per batch.
As a multi-peptide blend, GLOW does not have a single CAS number or molecular formula - each component peptide retains its own chemical identity within the vial. PhaseOne manufactures it to research-grade standards with full third-party testing, shipped Australia-wide. (!) Full Certificate of Analysis available for every batch view here.
GLOW peptide is not a single compound — it is a blend of three: GHK-Cu, BPC-157 and TB-500, supplied together in one 70mg vial as a lyophilised powder. You will also see it written GLOW blend, GLOW stack or GLOW 70mg.
GLOW combines GHK-Cu, BPC-157, and TB-500 in one vial. (!) Read about each individually: GHK-Cu, BPC-157, and TB-500.
Both share the same three peptides — GHK-Cu, BPC-157 and TB-500. KLOW adds a fourth, KPV, and comes as an 80mg vial against GLOW's 70mg. If the research question involves KPV's inflammatory-pathway activity, KLOW is the one; otherwise GLOW covers the same three. (!) Compare our KLOW Blend or view KPV on its own.
GHK-Cu is one of the three peptides in GLOW, alongside BPC-157 and TB-500. Buying GHK-Cu separately gives you that single compound at a higher individual quantity; the blend gives all three at fixed proportions in one vial. Which suits depends on whether the research design isolates the copper peptide or looks at the combination. (!) View our GHK-Cu.
PhaseOne ships the GLOW blend Australia-wide for research use, dispatched locally with tracking, in 70mg vials. Every vial carries a batch-specific Certificate of Analysis verifying ≥99% HPLC purity across all three components.
Yes — PhaseOne has the GLOW blend for sale online in 70mg vials, shipped Australia-wide. With any three-peptide blend the thing to check is whether the Certificate of Analysis covers every component or only one; PhaseOne tests all three per batch.
PhaseOne prices the GLOW blend at A$143.99 for the 70mg vial, with the batch Certificate of Analysis included at no extra cost. The four-peptide KLOW blend is A$162.99.
The blend arrives pre-combined at fixed proportions and needs reconstituting once, which suits designs using all three at a set ratio. Three separate vials cost more in total but let each be varied independently. (!) View GHK-Cu, BPC-157 and TB-500 individually.
No. None of the three peptides in GLOW is registered on the ARTG or approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock the blend or its components. They are supplied as research compounds through research suppliers instead.
Each peptide is studied for a distinct mechanism - GHK-Cu's copper-chelating and collagen-related signalling, BPC-157's gut and regenerative pathways, and TB-500's cellular migration research - making the blend of interest for researchers studying skin and tissue-related signalling together, and a combination frequently discussed within Australian peptide research communities.
The GLOW Blend should be stored refrigerated, unreconstituted, and protected from light, and is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.
Every batch of the GLOW Blend sold across Australia is independently HPLC tested, with a Certificate of Analysis verifying all three peptide components.
Yes - PhaseOne provides a peptide dosage calculator researchers can use as a reference tool when planning reconstitution and dilution. Use our peptide dosage calculator.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
